9-95508364-T-TGCCGCC
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_000264.5(PTCH1):c.-9_-4dupGGCGGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000961 in 1,163,802 control chromosomes in the GnomAD database, including 5 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0036 ( 4 hom., cov: 22)
Exomes 𝑓: 0.00058 ( 1 hom. )
Consequence
PTCH1
NM_000264.5 5_prime_UTR
NM_000264.5 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.30
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 9-95508364-T-TGCCGCC is Benign according to our data. Variant chr9-95508364-T-TGCCGCC is described in ClinVar as [Likely_benign]. Clinvar id is 255668.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00356 (527/147840) while in subpopulation AFR AF= 0.0114 (464/40744). AF 95% confidence interval is 0.0105. There are 4 homozygotes in gnomad4. There are 253 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High AC in GnomAd4 at 527 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTCH1 | NM_000264.5 | c.-9_-4dupGGCGGC | 5_prime_UTR_variant | 1/24 | ENST00000331920.11 | NP_000255.2 | ||
PTCH1 | NM_001083603.3 | c.199-1771_199-1766dupGGCGGC | intron_variant | ENST00000437951.6 | NP_001077072.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTCH1 | ENST00000331920.11 | c.-9_-4dupGGCGGC | 5_prime_UTR_variant | 1/24 | 5 | NM_000264.5 | ENSP00000332353.6 | |||
PTCH1 | ENST00000437951.6 | c.199-1771_199-1766dupGGCGGC | intron_variant | 5 | NM_001083603.3 | ENSP00000389744.2 |
Frequencies
GnomAD3 genomes AF: 0.00356 AC: 526AN: 147734Hom.: 4 Cov.: 22
GnomAD3 genomes
AF:
AC:
526
AN:
147734
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000670 AC: 1AN: 1492Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 862
GnomAD3 exomes
AF:
AC:
1
AN:
1492
Hom.:
AF XY:
AC XY:
0
AN XY:
862
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000582 AC: 591AN: 1015962Hom.: 1 Cov.: 30 AF XY: 0.000530 AC XY: 255AN XY: 480704
GnomAD4 exome
AF:
AC:
591
AN:
1015962
Hom.:
Cov.:
30
AF XY:
AC XY:
255
AN XY:
480704
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00356 AC: 527AN: 147840Hom.: 4 Cov.: 22 AF XY: 0.00351 AC XY: 253AN XY: 72036
GnomAD4 genome
AF:
AC:
527
AN:
147840
Hom.:
Cov.:
22
AF XY:
AC XY:
253
AN XY:
72036
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 03, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Aug 26, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | PTCH1: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 28, 2015 | - - |
Gorlin syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 11, 2019 | - - |
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at